<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04443816</url>
  </required_header>
  <id_info>
    <org_study_id>NL6152310017</org_study_id>
    <nct_id>NCT04443816</nct_id>
  </id_info>
  <brief_title>Advanced Geriatric Evaluation and Quality of Life in Colorectal Cancer Surgery</brief_title>
  <acronym>AGE CRC</acronym>
  <official_title>Advanced Geriatric Evaluation in Predicting Health Related Quality of Life in Patients With Colorectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Antonius Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Antonius Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Colorectal cancer (CRC) disproportionately affects patients aged 70 years and older. Surgery&#xD;
      is the main treatment modality for CRC, but is associated with increased risk of&#xD;
      postoperative morbidity, disability and loss of health related quality of life (HRQL).Frailty&#xD;
      is an age related state of functional decline and considered to be an important risk factor&#xD;
      for adverse outcome in geriatric oncology.Risk models for adverse outcome may be used for&#xD;
      treatment decisions in the elderly, but are often not designed to predict patient related&#xD;
      outcome measures and do not include frailty characteristics.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multicentre, prospective, observational cohort study with a follow up time of one year. After&#xD;
      initial diagnosis of CRC subjects will be screened for frailty using validated&#xD;
      questionnaires, physical tests and non-invasive measurements. Frailty characteristics and&#xD;
      HRQL are determined by Geriatric 8 (G8), Hospital Anxiety and Depression Scale(HADS),&#xD;
      Euroqol- 5 dimensional (EQ-5D), Lawton Instrumental Activity of Daily Living scale(IADL),&#xD;
      Mini Nutrition Assessment (MNA), 6 Item Cognitive Impairment Test (6-CIT), Identification of&#xD;
      Seniors At Risk - Hospitalized Patients(ISAR-HP) and the EORTC-QLQ-C30/CR29 (HRQL in CRC&#xD;
      patients). Physical tests include the Timed to Get Up (TUG) test and the hand grip strength&#xD;
      test. Furthermore, the non-invasive measurements consist of a sarcopenia analysis using an&#xD;
      existing CT/MRI scan and measurement of Advanced Glycation Endproducts (AGE reader).&#xD;
&#xD;
      Additional patients characteristics including medication use, medical history, tumor&#xD;
      characteristics, neoadjuvant therapy and laboratory results of preoperative routine blood&#xD;
      sampling will be collected. At three, six and twelve months after diagnosis, EORTC&#xD;
      QLQ-C30/EORTC QLQ-CR29 and EQ-5D questionnaires are used to determine HRQL and disability&#xD;
      free survival.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">July 6, 2021</completion_date>
  <primary_completion_date type="Actual">July 6, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Loss of health related quality of life (HRQL)</measure>
    <time_frame>12 months</time_frame>
    <description>Change in EORTC QLQ-C30</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Loss of health related quality of life (HRQL)</measure>
    <time_frame>3 months</time_frame>
    <description>Change in EORTC QLQ-C30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>30 days</time_frame>
    <description>Complication after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disability</measure>
    <time_frame>12 months</time_frame>
    <description>EQ-5D</description>
  </secondary_outcome>
  <enrollment type="Actual">273</enrollment>
  <condition>Colorectal Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        aged ≥ 70 years with a new diagnosis of non-metastatic CRC&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 70 years&#xD;
&#xD;
          -  Histologically proven non-metastatic colorectal cancer&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - Emergency surgical procedures&#xD;
&#xD;
          -  Insufficient understanding of the Dutch language&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Meander medical center</name>
      <address>
        <city>Amersfoort</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tergooi hospital</name>
      <address>
        <city>Hilversum</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rivierenland ziekenhuis</name>
      <address>
        <city>Tiel</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diakonessenhuis</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMCU</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 19, 2020</study_first_submitted>
  <study_first_submitted_qc>June 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2020</study_first_posted>
  <last_update_submitted>September 24, 2021</last_update_submitted>
  <last_update_submitted_qc>September 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Antonius Hospital</investigator_affiliation>
    <investigator_full_name>dr. P. Noordzij</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

